Background: Treatment has improved HIV infection prognosis, but whether risk and health care seeking behavior have improved is unclear. Methods: New entrants to HIV care at University Hospitals of Cleveland, Ohio, between 1995 and 2002, with no history of AIDS-defining illnesses or antiretroviral exposure were included. Results: Of new patients, 806 (80%) met the inclusion criteria. Median age increased during the study period (35.2 to 38.6 years; P < .001); proportions of females and nonwhites increased nonsignificantly. Prevalence of AIDS-defining illnesses decreased from 1995 to 1996 (25.0% to 14.2%; P < .001) but remained stable thereafter. Category B conditions and sexually transmitted diseases decreased significantly (31.7% to 9.1%; P = .039 and 22.5% to 8.0%; P = .003), as did hepatitis B and C seroprevalence (8.3% to 3.6%; P = .05 and 26.2% to 14.3%; P = .003). Median CD4 counts and HIV RNA did not change significantly. Conclusions: Prevalence of Category B conditions, sexually transmitted diseases, and hepatitis B and C declined significantly in this study. Prevalence of AIDSdefining illnesses decreased early in the highly active antiretroviral therapy era only, whereas markers of HIV disease stage remained stable, suggesting a need for earlier recognition of infection. Decreasing sexually transmitted diseases and hepatitis coinfections suggest that HIV infection is increasingly seen in populations previously perceived at lower risk.
The introduction and widespread use of highly active antiretroviral therapy (HAART) and chemoprophylaxis against opportunistic infections (OIs) has led to extraordinary changes in the clinical features of HIV disease. The overall mortality and incidence of severe OIs have declined significantly since 1995, [1] [2] [3] and the availability of more convenient and better tolerated antiretroviral medications has enhanced quality of life in persons living with HIV-1 infection. 4 The aim of our survey was to examine trends in characteristics of HIV-infected persons new to HIV care in Cleveland, Ohio, in the HAART era.
Patients and Methods
Subjects were identified by querying the Special Immunology Unit Patient Care and Research Database (PCRDB). The PCRDB is a real-time SQL database that is populated through systematic recording of clinical, laboratory, and sociodemographic data derived from every provider-patient encounter at the John T. Carey Special Immunology Unit, the largest HIV care provider in Cleveland, Ohio. Laboratory information is transferred electronically from the clinical laboratory's system, and medication information is entered by clinicians at the time of each prescription or change in pharmacologic management. Data quality and integrity are ascertained through a random chart review process, direct physician contact for clarification of equivocal data, and redundant quality control checks. From PCRDB records, we identified 1066 patients who sought treatment for the first time at the Special Immunology Unit during the 8year period from 1995 to 2002. To ensure that the analysis reflected individuals seeking HIV medical care for the first time, we excluded patients with a historical (more than 3 months before initial visit) diagnosis of OIs or any prior antiretroviral therapy. Eight hundred and six subjects (80.1%) fulfilled these criteria and were included in this analysis. Because of patient recall bias or reporting errors, date of first positive HIV test was considered unreliable to serve as a baseline for our study.
We obtained information on demographics, Category C AIDS-defining illnesses and Category B symptomatic conditions occurring before the initial visit to up to 6 months thereafter, previous or current sexually transmitted diseases (STDs), presence of hepatitis B surface antigen and antibody (HBsAg, HBsAb) and hepatitis C antibody (HCV Ab), CD4 counts, and HIV-1 viral load (VL) at baseline.
The US Centers for Disease Control and Prevention (CDC) Revised Classification System for HIV infection 5 was used for Category C and B illnesses.
Trends were analyzed using linear regression analysis and nonparametric tests (SPSS version 11.0, SPSS Science Inc, Chicago, Ill), and a value of P less than .05 was accepted as nominally significant.
Results
Between 1995 and 2002, we identified 806 patients seeking care for the first time. These patients were 78% male, 38.5% non-Hispanic whites, 55% African Americans, and 4% Hispanics. Median age was 36.3 years (range, 16.3-75.1 years). Homosexual/bisexual men represented 56% of the study group, and 33% had a history of drug use. These demographics closely resemble those of persons living with HIV/AIDS in northeast Ohio. During the study period, the yearly number of entrants ranged from 75 to 120 (Table 1) .
Population demographics by calendar year are also presented in Table 1 . There was a significant trend toward increasing median age (35.2 to 38.6 years; P < .001) but nonsignificant trends toward increasing proportions of female patients (16.0% to 20.5%; P = .10) and racial ethnic groups other than non-Hispanic whites (61% to 66%; P = .94). The proportion of homosexual/ bisexual men showed a nonsignificant decrease (from 67% to 60%; P = .39).
Major AIDS-defining illnesses and CDC Category B conditions are shown in Tables 2 and 3, respectively. The cumulative proportion of patients presenting with AIDSdefining illnesses (AIDS-defining diagnosis no more than 3 months before presentation; Table 4 ) decreased from 1995 to 1996 (25% to 14%; P < .001) but remained stable thereafter. During this period, there was a marginally significant decrease in the frequency of CDC Category B conditions in new entrants (P = .039), but importantly, median CD4 counts at entry remained stable, as did median entry plasma HIV-1 RNA levels. For the overall cohort, median CD4 counts and plasma HIV RNA at baseline were 300 cells/mm 3 and 30 560 copies/mL, and these markers did not change significantly during the study period (280 to 342 cells/mm 3 ; P = .36 and 27 400 to 38 500 copies/mL, P = .06, respectively) ( Table 5 ).
The proportion of new entrants with a history of STDs fell progressively during this period from 22.5% to 8.0%, P = .003. Of the entrants to care, 86% were screened for HBsAg/HBsAb and 84% for HCV Ab. The overall seroprevalences of hepatitis B (HBsAg+) and hepatitis C infections were 7% and 18%, respectively. These prevalences also decreased significantly during the study period (from 8% to 4%; P = .05 and from 26% to 14%; P = .003, respectively, Table 6 ). The overall prevalence of HBsAb was 31% and did not change over time (P = .51). The proportion of entrants with a history of hepatitis B and/or hepatitis C and/or STDs was 36%, and this proportion decreased significantly during the study period (from 54% to 21%; P < .001). As expected, the prevalence of HCV coinfection was highest among subjects with a history of intravenous drug use. Among those with available risk behavior and HCV serological data, 57.6% of HIV/HCV coinfected patients had a history of drug use, whereas 31.9% of drug users were HCV-infected.
Women had higher CD4 counts and lower VL than men at baseline (mean, 388 vs 310 cells/mm 3 ; P = .003, and 89 396 vs 126 537 copies/mL; P = .048, respectively), although there was no difference in the proportion of patients presenting with Category C AIDS-defining illnesses, Category B symptomatic conditions, and STD history between the 2 genders (P = .23, .63, and .42, respectively). Approximately one third (36%) of new entrants to care had CD4 counts less than 200 cells/mm 3 , and this proportion remained unchanged over time (P = .16).
Discussion
In this analysis, using a real-time AIDS patient care/clinical research database, we found that new entrants to HIV care between 1995 and 2002 tended to be older and were less likely to have Category B illnesses, hepatitis B or C infection, or a history of STDs. Presentation with, and presumably as a result of a major opportunistic infection, decreased dramatically in the first year of the study but remained relatively stable thereafter.
The aging of the newly identified HIV population in Western nations has been noted earlier in studies both in the United States and Spain. 6, 7 The decreasing prevalence of hepatitis B and C infection and the decreased proportion of patients with prior STDs might suggest that HIV infection is now occurring in populations previously perceived at lower risk for HIV. Indeed, the proportion of HIV-infected new entrants who had male homosexuality or bisexuality as their main risk factor decreased nonsignificantly over time, whereas the proportion of patients without serologic evidence of hepatitis B or C or without prior STDs increased significantly during the study period. An alternative hypothesis, that safe practices have been adopted by high-risk groups, is unlikely because available data suggest to the contrary that unsafe sexual practices 8 and STDs 9 are increasing at least among homosexual men in the United States.
In this retrospective study, women presenting for the first time for HIV care had lower plasma VL and higher CD4 counts than did male new entrants to care. Conceivably women have been presenting earlier in the course of disease than have men in Cleveland. On the other hand, other investigators have found lower levels of plasma HIV RNA in women in early disease 10,11 that likely represents a sex-dependent difference in cellular support for HIV replication; this assumption, however, is thus far unproven and the mechanisms for this dyssynchrony remain undetermined.
The life-saving effects of HAART are well established, 1,2 and overall mortality and incidence of severe OIs have declined significantly since 1995. 3 This dramatic change in prognosis could have provided motivation to persons at high risk to be screened for HIV, particularly as educational campaigns targeting high-risk groups have underscored the advantages of early diagnosis.
If the above hypothesis is correct, one might expect new entrants to HIV care to be healthier and to be presenting at an earlier stage of the disease and with fewer AIDS-defining illnesses and symptomatic conditions.
The results from our retrospective study are somewhat inconsistent. After an expected decrease in the proportion of patients presenting with AIDS-defining illnesses between 1995 and 1996, concordant with the introduction of combination antiretroviral therapies, the proportion of new entrants with AIDS-defining OIs at evaluation has remained stable. Likewise, median CD4 counts and plasma HIV RNA levels also remained stable during this period. On the other hand, there was a marginally significant trend toward fewer Category B conditions among new entrants to care. Also, the proportion of persons presenting with CD4 counts less than 200/ mm 3 , which would otherwise represent an absolute indication for antiviral therapy, 12 remained unchanged over time in our study. Similar results have been reported by other investigators. Sackoff and Shin found no important shift toward earlier HIV testing among newly diagnosed patients in New York City after the introduction of HAART; in that study, most newly diagnosed patients were immunosuppressed and symptomatic. 13 Our results suggest that broader interventions aimed at earlier detection of HIV infection and treatment of emerging cases are needed. According to the CDC, only 10% of newly diagnosed men and 17% of women were tested because the test was offered or recommended by a health care facility or provider; 42% of the newly diagnosed sought the test because of illness. 14 Also, according to the same CDC data, in the year 2000, 31% of persons with positive tests did not return to learn the results. In this regard, most recent (2003) CDC guidelines advocate offering HIV testing on a voluntary basis as a routine part of medical care. 14 Our findings that new entrants to HIV care now less frequently have hepatitis virus infection or a prior history of STDs suggest that these persons are more likely to be drawn from groups not recognized as at risk for HIV care, thus underscoring the importance of the current CDC screening recommendations.
Our findings must be considered in light of at least 3 limitations. First, self-reported data are subject to recall bias or to other reporting errors. This type of bias, however, is minimized in this study by the use of real-time data collection at the time of physician encounters (as opposed to the setting of a structured longitudinal cohort study, in which data are collected after the fact through scheduled interviews). Second, some data may be missing or incorrectly entered. Nonetheless, because standard procedures are in place to ensure data quality and integrity (including random chart review, full update of data immediately before each physician encounter, electronic transmission of data, and restricted vocabulary for data entry), we are confident that this type of error is also small. Third, our study population, considered to represent patients seeking care for the first time, may include a small number of people who sought care elsewhere before and who in the absence of AIDS-defining illnesses were not treated with antiretroviral therapies.
In conclusion, in the HAART era we did not find clear evidence that HIV-infected persons in Cleveland are presenting for care at earlier stages of the disease. In fact, with median CD4 counts at entry stable at 350 cells/mm 3 or lower, one half or more of new entrants to HIV care are presenting after intervention with antiretroviral therapies may be indicated by current guidelines. 12 Most important, there is reason to believe that new entrants to HIV care more frequently represent populations previously perceived at lower risk for infection. Therefore, efforts to identify, educate, and provide screening to populations increasingly at risk are warranted. 
